Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive
Status:
Completed
Trial end date:
2022-12-23
Target enrollment:
Participant gender:
Summary
Comparison of Efficacy and Ocular Surface Disease Assessment between BRIDIN-plus Eye drops
and Combigan Eye drops in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group
Design, Investigator-blind, Active-control, Randomized, Multi-center Trial